Effect of Ischemic Preconditioning on Lower Extremity Motor Ability and Recovery in Basketball Players During Post-Match Recovery Period
21 de mayo de 2026 actualizado por: Ziyue Ou, Guangzhou Sport University
Effect of Ischemic Preconditioning on Lower Extremity Motor Ability and Recovery in Basketball Players During Post-Match Recovery Period: A Randomized Controlled Trial
This study aimed to evaluate the effects of ischemic preconditioning on lower limb explosive power and post-exercise recovery in basketball players during a 6-week post-season recovery training period.
Thirty-four male collegiate basketball players were randomly assigned to either an IPC group or a placebo control group.
Bilateral lower limb IPC intervention (3 cycles, each consisting of 5-minute ischemia at 220 mmHg and 5-minute reperfusion, twice per week for 6 weeks) was administered before routine basketball training sessions.
Lower limb explosive power, as well as physiological, biochemical, and morphological indices, were assessed before and after the intervention.
Descripción general del estudio
Estado
Reclutamiento
Condiciones
Intervención / Tratamiento
Descripción detallada
Background: Lower limb explosive power is crucial for basketball performance, and effective recovery strategies are key to maintaining training quality.
Ischemic preconditioning (IPC) is a non-invasive, economical, and safe method that triggers endogenous protective mechanisms through brief ischemia-reperfusion cycles, showing potential in enhancing athletic performance and metabolic efficiency.
However, the effects of IPC on lower limb explosive power during post-match recovery in basketball players remain understudied.
Objective: To investigate the effects of a 6-week repeated remote ischemic preconditioning on lower limb explosive power, phosphagen energy system capacity, and physical recovery in male college basketball players.
Design: A randomized, parallel-group, placebo-controlled trial with concealed allocation.
Participants were randomly assigned to either the IPC experimental group (n=17) or the placebo control group (n=17).
Both groups participated in the same regular basketball sessions.
The experimental group received bilateral thigh IPC intervention (3×5 minutes, 220 mmHg) before each training session, while the control group received a placebo intervention (3×5 minutes, 20 mmHg).
The intervention was administered twice a week for 6 weeks (30 minutes per session).
Secondary endpoints: Urinary creatinine coefficient, 10-second maximal load test (blood lactate increment, peak power, mean power), hematological parameters (red blood cell count, hemoglobin, hematocrit, white blood cell count), serum testosterone, cortisol, testosterone/cortisol ratio, body composition (body weight, body fat percentage, BMI), and training load monitoring (heart rate, RPE, urine protein).
Tipo de estudio
Intervencionista
Inscripción (Estimado)
34
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
- Nombre: Ziyue Ou, PHD
- Número de teléfono: +8615626121623
- Correo electrónico: 105852022100090@stu.gzsport.edu.cn
Ubicaciones de estudio
-
-
Guangdong
-
Guangzhou, Guangdong, Porcelana, 510430
- Reclutamiento
- Guangzhou Sport University
-
Contacto:
- Ziyue Ou, PHD
- Número de teléfono: 15626121623
- Correo electrónico: 105852022100090@stu.gzsport.edu.cn
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Sí
Descripción
Inclusion Criteria:
- Male basketball students at Guangzhou Sport University.
- Regular participants in basketball training/practice.
- Healthy adults without cardiovascular, hepatic, renal, digestive, neurological, or metabolic diseases.
- Blood pressure within normal range.
- No history of lower extremity musculoskeletal injury within the past 6 months.
- Not currently using any performance-enhancing substances or medications affecting hormones/metabolism.
- Voluntary participation with signed informed consent.
Exclusion Criteria:
- Presence of acute or chronic diseases affecting exercise performance.
- History of deep vein thrombosis or coagulation disorders.
- Presence of skin lesions or infections at the thigh cuff placement site.
- Participation in other concurrent lower extremity strength/power training programs outside the study.
- Use of dietary supplements known to affect muscle metabolism within 4 weeks prior to enrollment.
- Inability to complete the full 6-week intervention and testing protocol.
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: IPC Group
Bilateral thigh compression was applied using a Theratools pneumatic cuff (T-bfr-0475).
Three cycles, each consisting of 5 minutes of ischemia (pressure 220 mmHg) and 5 minutes of reperfusion (total 30 minutes), were performed before regular basketball training sessions.
The intervention was conducted twice per week for 6 weeks.
Cuff placement: at the inguinal crease of the thigh.
Subject position: supine, alternating between left and right legs.
|
Bilateral thigh compression was applied using a Theratools pneumatic cuff (T-bfr-0475).
Three cycles, each consisting of 5 minutes of ischemia (pressure 220 mmHg) and 5 minutes of reperfusion (total 30 minutes), were performed before regular basketball training sessions.
The intervention was conducted twice per week for 6 weeks.
Cuff placement: at the inguinal crease of the thigh.
Subject position: supine, alternating between left and right legs.
|
|
Comparador activo: Sham Control Group
Identical procedure to IPC group except cuff pressure maintained at 20 mmHg (non-ischemic), applied before regular basketball training.
Twice weekly for 6 weeks.
|
Identical procedure to IPC group except cuff pressure maintained at 20 mmHg (non-ischemic), applied before regular basketball training.
Twice weekly for 6 weeks.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Squat Jump (SJ) height
Periodo de tiempo: Baseline (Week 0) and Post-intervention (Week 8)
|
Change from baseline in lower extremity concentric explosive power measured by Smart Jump portable contact mat (cm).
|
Baseline (Week 0) and Post-intervention (Week 8)
|
|
Countermovement Jump (CMJ) height
Periodo de tiempo: Baseline and Week 8
|
Change from baseline in lower extremity reactive explosive power without arm swing (cm).
|
Baseline and Week 8
|
|
Standing Long Jump
Periodo de tiempo: Baseline and Week 8
|
Change from baseline in lower extremity horizontal explosive power (cm).
|
Baseline and Week 8
|
|
T-Test (T-run)
Periodo de tiempo: Baseline and Week 8
|
Change from baseline in multi-directional agility performance (seconds).
|
Baseline and Week 8
|
|
3/4 Court Sprint
Periodo de tiempo: Baseline and Week 8
|
Change from baseline in linear sprint speed over 3/4 basketball court distance (~21m, seconds).
|
Baseline and Week 8
|
|
Reactive Strength Index (RSI)
Periodo de tiempo: Baseline and Week 8
|
Change from baseline in RSI derived from 30cm drop jump using Smart Jump system (m/s).
The RSI was calculated as jump height divided by ground contact time, with higher values indicating better reactive strength capacity in athletes (i.e., shorter ground contact times and greater jump heights).
The observed range of RSI in the present study was [minimum value]-[maximum value] m/s.
|
Baseline and Week 8
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Blood Lactate Accumulation
Periodo de tiempo: Baseline and Week 8
|
Change in blood lactate accumulation during 10-second maximal load test (mmol/L).
|
Baseline and Week 8
|
|
Peak Power (10s Test)
Periodo de tiempo: Baseline and Week 8
|
Change from baseline in peak power output during 10-second maximal load test on Monark 828E cycle ergometer (Watts).
|
Baseline and Week 8
|
|
Mean Power (10s Test)
Periodo de tiempo: Baseline and Week 8
|
Change from baseline in mean power output during 10-second maximal load test (Watts).
|
Baseline and Week 8
|
|
Testosterone/Cortisol Ratio
Periodo de tiempo: Baseline and Week 8
|
Change from baseline in T/C ratio (×10-²).
|
Baseline and Week 8
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Publicaciones y enlaces útiles
La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.
Publicaciones Generales
- Jean-St-Michel E, Manlhiot C, Li J, Tropak M, Michelsen MM, Schmidt MR, McCrindle BW, Wells GD, Redington AN. Remote preconditioning improves maximal performance in highly trained athletes. Med Sci Sports Exerc. 2011 Jul;43(7):1280-6. doi: 10.1249/MSS.0b013e318206845d.
- Bailey TG, Jones H, Gregson W, Atkinson G, Cable NT, Thijssen DH. Effect of ischemic preconditioning on lactate accumulation and running performance. Med Sci Sports Exerc. 2012 Nov;44(11):2084-9. doi: 10.1249/MSS.0b013e318262cb17.
- Cheng CF, Kuo YH, Hsu WC, Chen C, Pan CH. Local and Remote Ischemic Preconditioning Improves Sprint Interval Exercise Performance in Team Sport Athletes. Int J Environ Res Public Health. 2021 Oct 12;18(20):10653. doi: 10.3390/ijerph182010653.
- Chen Y, Yang J, Muradov O, Li X, Lee JKW, Qiu J. Effect of ischemic preconditioning on maximum accumulated oxygen deficit in 400-meter runners. Eur J Sport Sci. 2023 May;23(5):789-796. doi: 10.1080/17461391.2022.2064769. Epub 2022 Apr 25.
- Caru M, Levesque A, Lalonde F, Curnier D. An overview of ischemic preconditioning in exercise performance: A systematic review. J Sport Health Sci. 2019 Jul;8(4):355-369. doi: 10.1016/j.jshs.2019.01.008. Epub 2019 Jan 23.
- Ou Z, Yang L, Zhu H, Weng X, Xu G. Ischemic preconditioning enhances autonomic nervous system modulation during frequency speed of kick test in taekwondo athletes: a randomized crossover study. BMC Sports Sci Med Rehabil. 2026 Feb 12;18(1):136. doi: 10.1186/s13102-026-01602-2.
- Carvalho L, Barroso R. Ischemic Preconditioning Improves Strength Endurance Performance. J Strength Cond Res. 2019 Dec;33(12):3332-3337. doi: 10.1519/JSC.0000000000002846.
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
22 de mayo de 2026
Finalización primaria (Estimado)
15 de julio de 2026
Finalización del estudio (Estimado)
15 de julio de 2026
Fechas de registro del estudio
Enviado por primera vez
17 de mayo de 2026
Primero enviado que cumplió con los criterios de control de calidad
17 de mayo de 2026
Publicado por primera vez (Actual)
22 de mayo de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
26 de mayo de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
21 de mayo de 2026
Última verificación
1 de mayo de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- GZSU-IPC-BB-2024
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
INDECISO
Descripción del plan IPD
The data have not been publicly released yet, and contributions may be considered after they are published.
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .